首页> 外文期刊>The Journal of Clinical Pharmacology: Official Journal of the American College of Clinical Pharmacology >Coenzyme Q10 in combination with triple therapy regimens ameliorates oxidative stress and lipid peroxidation in chronic gastritis associated with H-pylori infection
【24h】

Coenzyme Q10 in combination with triple therapy regimens ameliorates oxidative stress and lipid peroxidation in chronic gastritis associated with H-pylori infection

机译:辅酶Q10与三联疗法相结合可改善与H幽门螺杆菌感染相关的慢性胃炎的氧化应激和脂质过氧化

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic gastritis associated with H. pylori infection causes oxidative stress in the stomach. This study aimed to evaluate the therapeutic effects of coenzyme q10 among gastric patients infected by H. pylori. By a clinical trial, chronic gastric patients infected by H. pylori were randomly divided into 2 groups: intervention and placebo. The placebo group received a standard triple therapy regimen, and the intervention group received the triple regimen+coenzyme Q10 (CoQ10). Mean inflammation score; serum levels of 3 serum markers were then compared. A total of 100 participants of whom 67% were female were evaluated. The mean age of participants was 59.4 +/- 11.4 years. The mean inflammation score was considerably decreased at the end of the study, in the intervention group. The mean levels of total antioxidant capacity (TAC) and glutathione peroxidase (GPx) at the end of the study were reduced among the triple therapy group (P<.05, P=.03 respectively). The mean levels of TAC and GPx were significantly higher among the intervention group at the end of the study compared with those at the start of the study. The combination of triple therapy with CoQ10 demonstrated an effective outcome on the mucosal inflammation, and stress oxidative in patients with chronic gastritis.
机译:与幽门螺杆菌感染相关的慢性胃炎在胃中引起氧化应激。这项研究旨在评估辅酶q10在幽门螺杆菌感染的胃病患者中的治疗效果。通过一项临床试验,被幽门螺杆菌感染的慢性胃病患者被随机分为两组:干预组和安慰剂组。安慰剂组接受标准三联疗法,干预组接受三联疗法+辅酶Q10(CoQ10)。平均炎症评分;然后比较三种血清标志物的血清水平。共评估了100位参与者,其中67%是女性。参与者的平均年龄为59.4 +/- 11.4岁。在研究结束时,干预组的平均炎症评分明显降低。在三项治疗组中,研究结束时平均总抗氧化剂能力(TAC)和谷胱甘肽过氧化物酶(GPx)的水平降低(分别为P <.05,P = .03)。与研究开始时相比,研究结束时干预组中TAC和GPx的平均水平显着更高。三联疗法与辅酶Q10的结合对慢性胃炎患者的粘膜炎症和应激氧化具有有效的效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号